J. Curtis

发表

Systemic hypertension and the kidney in black patients.

H. Dustan, R. Luke, S. Rostand, 1987, The American journal of cardiology.

The Impact of Left Ventricular Systolic Dysfunction on Survival After Renal Transplantation

A. Iskandrian, G. Perry, R. Gaston, 2007, Transplantation.

Experience with Mycophenolate Mofetil (RS61443) in Renal Transplantation at a Single Center

B. Julian, R. Gaston, M. Deierhoi, 1993, Annals of surgery.

OKT3 first-dose reaction: association with T cell subsets and cytokine release.

B. Julian, R. Gaston, M. Deierhoi, 1991, Kidney international.

Role of hypertension in chronic renal allograft dysfunction.

J. Curtis, C. E. Sanders, 1995, Kidney international. Supplement.

Enteric‐Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1‐Year Study

Y. Seifu, K. Budde, G. Knoll, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCE

R. Luke, J. Whelchel, A. Diethelm, 1986, The Lancet.

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.

B. Julian, M. Deierhoi, A. Diethelm, 1991, Transplantation.

Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.

B. Julian, J. Prchal, T. Stopka, 1998, Journal of the American Society of Nephrology : JASN.

Effect of alternate-day prednisone on plasma lipids in renal transplant recipients.

R. Luke, J. Curtis, B. Lucas, 1982, Kidney international.

Transplant Immunosuppressive Drug Trials on Trial

B. Kaplan, J. Curtis, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Kidney transplantation for older patients with renal disease

J. Curtis, 2005 .

Clinical documentation of end-stage renal disease due to hypertension.

J. Curtis, S. Schlessinger, M. Tankersley, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hepatitis C and management of end-stage renal disease.

J. Curtis, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.

J. Kovarik, M. Pescovitz, D. Hricik, 2006, Transplantation proceedings.

Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis: serial complement and nephritic factor measurements and the problem of recurrence of disease.

R. Wyatt, R. Luke, D. Bhathena, 1979, The American journal of medicine.

A possible relationship between Henoch-Schonlein syndrome and IgA nephropathy (Berger's disease). An illustrative case.

R. Luke, D. Bhathena, J. Curtis, 1978, Nephron.

A Possible Relationship between Henoch-Schonlein Syndrome and IgA Nephropathy (Berger’s Disease)

R. Luke, D. Bhathena, J. Curtis, 1978 .

Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis.

B. Julian, G. Krystal, R. Gaston, 1994, Kidney international.

Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up.

B. Julian, R. Gaston, M. Deierhoi, 2001, Transplantation.

Renal vein thrombosis in IgA nephropathy.

R. Luke, J. Curtis, R. McMorrow, 1980, Archives of internal medicine.

Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation

B. Julian, W. Cook, D. Eckhoff, 2006, Annals of Internal Medicine.

Posttransplant erythrocytosis: an enigma revisited.

B. Julian, R. Gaston, J. Curtis, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Enalapril: safe and effective therapy for posttransplant erythrocytosis.

B. Julian, R. Gaston, A. Diethelm, 1993, Transplantation proceedings.

A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.

B. Julian, B. Barger, M. Deierhoi, 1988, American Journal of Kidney Diseases.

Remission of essential hypertension after renal transplantation.

M. Kashgarian, H. Dustan, R. Luke, 1983, The New England journal of medicine.

Dilemmas in renal transplantation: when the clinical course and histological findings differ.

B. Julian, R. Gaston, J. Curtis, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney transplantation: racial or socioeconomic disparities?

J. Curtis, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Remission of essential hypertension after renal transplantation.

M. Kashgarian, H. Dustan, R. Luke, 1983, The New England journal of medicine.

SURGICAL THERAPY FOR PERSISTENT HYPERTENSION AFTER RENAL TRANSPLANTATION

T. Kotchen, R. Luke, J. Curtis, 1981, Transplantation.

Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule.

D. Warnock, J. Curtis, M. Botero-Velez, 1994, The New England journal of medicine.

Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent.

R. Luke, A. Diethelm, J. Curtis, 1988, The American journal of medicine.

Cyclosporine and posttransplant hypertension.

J. Curtis, 1992, Journal of the American Society of Nephrology : JASN.

IMPROVED SURVIVAL OF PRIMARY CADAVERIC RENAL ALLOGRAFTS IN BLACKS WITH QUADRUPLE IMMUNOSUPPRESSION1

B. Julian, B. Barger, R. Gaston, 1992, Transplantation.

J. Curtis, M. Said, 1998, Journal of the American Society of Nephrology : JASN.

Experience with cyclosporine.

J. Curtis, 2004, Transplantation proceedings.

Hypertension following kidney transplantation.

J. Curtis, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of enalapril on erythrocytosis after renal transplantation.

B. Julian, R. Gaston, A. Diethelm, 1991, Annals of internal medicine.

Hypertension after renal transplantation.

J. Curtis, 1984, The Alabama journal of medical sciences.

Benefits of continued cyclosporine through an indigent drug program.

B. Julian, R. Gaston, M. Deierhoi, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients.

B. Julian, G. Knoll, J. Curtis, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Medical Management of Renal Transplant Patients

J. Curtis, 1987 .

Hypertension after renal transplantation: cyclosporine increases the diagnostic and therapeutic considerations.

J. Curtis, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients.

D. Warnock, R. Gaston, P. Sanders, 1995, Journal of the American Society of Nephrology : JASN.

Hypertension and kidney transplantation.

J. Curtis, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

RENAL RETRANSPLANTATION: THE ROLE OF RACE, QUADRUPLE IMMUNOSUPPRESSION, AND THE FLOW CYTOMETRY CROSS‐MATCH

B. Julian, B. Barger, R. Gaston, 1994, Transplantation.

The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).

M. Deierhoi, A. Diethelm, J. Curtis, 1994, Transplantation.

Post-transplant hypertension.

J. Curtis, D. Laskow, Laskow Da, 1990, American journal of hypertension.

Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations.

A. Monaco, M. First, V. Armenti, 1996, Clinical transplantation.

BENEFITS OF REMOVAL OF NATIVE KIDNEYS IN HYPERTENSION AFTER RENAL TRANSPLANTATION

R. Luke, J. Whelchel, A. Diethelm, 1985, The Lancet.

Hypertension after successful renal transplantation.

R. Luke, J. Whelchel, A. Diethelm, 1985, The American journal of medicine.

Effect of prednisone dose spacing on plasma lipids.

G. Somes, R. Luke, J. Curtis, 1980, The Journal of laboratory and clinical medicine.

Cyclosporine-induced changes in glomerular filtration rate and urea excretion.

B. Julian, M. Deierhoi, R. Luke, 1990, The American journal of medicine.

Distinguishing the causes of post-transplantation hypertension

J. Curtis, 2004, Pediatric Nephrology.

Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.

J. W. Mcroberts, T. Kotchen, R. Luke, 1976, Clinical nephrology.

The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center.

B. Julian, B. Barger, R. Gaston, 1992, Transplantation.

Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study.

B. Julian, T. Pesavento, J. Curtis, 1996, Journal of the American Society of Nephrology : JASN.

Comparison of daily and alternate-day prednisone during chronic maintenance therapy: a controlled crossover study.

R. Luke, J. Curtis, J. Galla, 1981, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypertensinogenic mechanism of the calcineurin inhibitors

J. Curtis, 2002, Current hypertension reports.

Possible mediators in hypertension: renal factors.

S. Bergman, J. Curtis, 1996, Seminars in nephrology.

Preferential rejection of the kidney in a simultaneous kidney-pancreas transplant.

J. Curtis, J. Rice, D. Laskow, 1994, Journal of the American Society of Nephrology : JASN.

Nonadherence

J. Curtis, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hemodialysis without anticoagulation.

P. Sanders, J. Curtis, H. Taylor, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Are black living-related renal donors at greater long-term risk of renal complications than white donors?

B. Julian, M. Deierhoi, A. Diethelm, 1991, Transplantation proceedings.

Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients.

B. Julian, R. Gaston, R. Luke, 1993, Journal of the American Society of Nephrology : JASN.

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Y. Seifu, K. Budde, G. Knoll, 2005, Transplantation proceedings.

Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

H. Dustan, R. Luke, J. Whelchel, 1983, The New England journal of medicine.

Progress in renal transplantation. A single center study of 3359 patients over 25 years.

B. Julian, R. Gaston, M. Deierhoi, 1995, Annals of surgery.

Prevention of Post‐transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group 1

B. Kasiske, F. Cosio, R. Wiesner, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cyclosporine-induced nephrotoxicity: pathophysiology of decreased blood flow.

J. Curtis, D. Laskow, 1988, Transplantation proceedings.

Important Risk Factors of Allograft Survival in Cadaveric Renal Transplantation A Study of 426 Patients

E. Blackstone, B. Barger, M. Deierhoi, 1988, Annals of surgery.

Focal and segmental glomerular sclerosis in reflux nephropathy.

R. Luke, D. Bhathena, J. Curtis, 1980, The American journal of medicine.

Controversy in renal transplantation: antireflux versus non-antireflux ureteroneocystostomy.

J. W. Mcroberts, R. Luke, J. Curtis, 1979, The Journal of urology.

Hypophosphatemia in thyrotoxic periodic paralysis.

J. Curtis, G. Guthrie, K. M. Beilman, 1978, Archives of internal medicine.

Hypertension in the renal transplant patient

J. Curtis, 1988 .

Sustained high panel reactive antibody levels in highly sensitized patients: significance of continued transfusions.

B. Julian, B. Barger, M. Deierhoi, 1989, Transplantation proceedings.

Cytomegalovirus glomerulopathy: a controversial lesion.

G. Herrera, R. Luke, R. Alexander, 1986, Kidney international.

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

F. Delmonico, A. Cosimi, N. Tolkoff-Rubin, 2003, Transplantation.

Large within-day variation in cyclosporine absorption: circadian variation or food effect?

J. Curtis, Patsy Jones, R. Barbeito, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Rapid loss of vertebral mineral density after renal transplantation.

B. Julian, L. Quarles, E. Dubovsky, 1991, The New England journal of medicine.

Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham.

B. Julian, B. Barger, R. Gaston, 1991, Clinical transplants.

Summary: Use of OKT3 to Treat Acute Rejection Episodes

J. Curtis, 1988 .

Management of hypertension after transplantation.

J. Curtis, 1993, Kidney international. Supplement.

Mechanisms of posttransplant hypertension.

R. Luke, J. Whelchel, A. Diethelm, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A Multicenter, Prospective Study of C2-Monitored Cyclosporine Microemulsion in a U.S. Population of De Novo Renal Transplant Recipients

F. Vincenti, S. Jordan, E. Akalin, 2005, Transplantation.

THE EFFECT OF PRETRANSPLANT STORED DONOR‐SPECIFIC BLOOD TRANSFUSION ON RENAL ALLOGRAFT SURVIVAL IN ONE‐HAPLOTYPE LIVING‐RELATED TRANSPLANT RECIPIENTS

B. Barger, R. Luke, J. Whelchel, 1984, Transplantation.

Goodpasture's syndrome in a patient with the Nail-Patella syndrome.

R. Luke, D. Bhathena, J. Curtis, 1976, The American journal of medicine.

Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.

M. Deierhoi, A. Diethelm, J. Curtis, 1989, Transplantation proceedings.

Recurrence of Wegener's granulomatosis in a cadaver renal allograft.

J. Whelchel, A. Diethelm, J. Curtis, 1983, Transplantation.

LACK OF BIOEQUIVALENCE OF TWO SANDIMMUNE® CYCLOSPORINE FORMULATIONS IN RENAL TRANSPLANT PATIENTS WHO ABSORB CYCLOSPORINE POORLY

J. Curtis, 1998 .

The best way to manage hypertension after renal transplantation.

J. Curtis, C. Kew, 2000, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Corticosteroids and kidney transplantation.

J. Curtis, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Increasing referral for renal transplant evaluation in recipients of nonrenal solid-organ transplants: a single-center experience.

J. Kirklin, David Naftel, A. Chandrakantan, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label Study

C. Ponticelli, G. Mourad, J. Jaffe, 2004, Transplantation.

Systolic dysfunction portends increased mortality among those waiting for renal transplant.

B. Julian, A. Iskandrian, C. Young, 2008, Journal of the American Society of Nephrology : JASN.

Impact of donor/recipient size matching on outcomes in renal transplantation.

B. Julian, R. Gaston, M. Deierhoi, 1996, Transplantation.

Tapering or discontinuing cyclosporine for financial reasons--a single-center experience.

B. Julian, R. Gaston, M. Deierhoi, 1993, American Journal of Kidney Diseases.

Chapter 59 – Hypertension in Renal Transplant Recipients

R. Gaston, J. Curtis, 2008 .

Ageism and Kidney Transplantation

J. Curtis, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Secondary Listing for Deceased‐Donor Kidney Transplantation Does Not Increase Likelihood of Engraftment at a Large Transplant Center

B. Julian, M. Deierhoi, J. Curtis, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Remission of essential hypertension after renal transplantation. Commentaries

E. Ritz, M. Kashgarian, H. Dustan, 2000 .

Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients.

J. Pirsch, J. Curtis, S. Choudhury, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Influence of race on renal allograft survival in the pre- and postcyclosporine era.

B. Julian, B. Barger, M. Deierhoi, 1987, Clinical transplants.

Judgmental sampling.

J. Curtis, 2011, Transplantation.

Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.

B. Julian, M. Deierhoi, A. Diethelm, 1989, Transplantation.

Effect of captopril on ERPF in differential diagnosis of hypertension in renal transplant recipients

R. Luke, J. Whelchel, E. Dubovsky, 1985 .

You Can Be a Kidney Transplant Donor but You Can't Be a Kidney Recipient

J. Curtis, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Variables affecting weight gain in renal transplant recipients.

J. Curtis, C. Y. Lin, C. Lin, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

EFFECT OF PRETRANSPLANT STORED DONOR‐SPECIFIC BLOOD TRANSFUSIONS ON EARLY RENAL ALLOGRAFT SURVIVAL IN ONE‐HAPLOTYPE LIVING RELATED TRANSPLANTS

J. F. Shaw, J. Whelchel, A. Diethelm, 1982, Transplantation.

SUCCESSFUL RENAL ALLOGRAFTS IN RECIPIENTS WITH CROSSMATCH‐POSITIVE, DITHIOERYTHRITOL‐TREATED NEGATIVE SERA

B. Julian, M. Deierhoi, R. Luke, 1989, Transplantation.

Effects of renal transplantation on hyperlipidemia and high-density lipoprotein cholesterol (HDL).

R. Luke, J. Curtis, E. D. Rees, 1978, Transplantation.

Neoral conversion from Sandimmune in maintenance renal transplant patients: an individualized approach.

M. Lynn, J. Curtis, P. Jones, 1998, Journal of the American Society of Nephrology : JASN.

Evaluation of percutaneous kidney biopsy in advanced renal failure.

G. Schreiner, W. Argy, T. Rakowski, 1976, Nephron.